Related Experiment Video
Updated: Jun 15, 2026

Isolation and Culture of Adult Mouse Cardiomyocytes for Cell Signaling and in vitro Cardiac Hypertrophy
Published on: May 21, 2014
Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes
Mei Hua Gao1, Tong Tang, Tracy Guo
1Veterans Administration San Diego Healthcare System, University of California, San Diego, La Jolla, California 92093, USA.
Abstract:
Increased expression of adenylyl cyclase VI has beneficial effects on the heart, but strategies that increase cAMP production in cardiac myocytes usually are harmful. Might adenylyl cyclase VI have beneficial effects unrelated to increased beta-adrenergic receptor-mediated signaling? We previously reported that adenylyl cyclase VI reduces cardiac phospholamban expression. Our focus in the current studies is how adenylyl cyclase VI influences phospholamban phosphorylation. In cultured cardiac myocytes, increased expression of adenylyl cyclase VI activates Akt by phosphorylation at serine 473 and threonine 308 and is associated with increased nuclear phospho-Akt. Activated Akt phosphorylates phospholamban, a process that does not require beta-adrenergic receptor stimulation or protein kinase A activation. These previously unrecognized signaling events would be predicted to promote calcium handling and increase contractile function of the intact heart independently of beta-adrenergic receptor activation. We speculate that phospholamban phosphorylation, through activation of Akt, may be an important mechanism by which adenylyl cyclase VI increases the function of the failing heart.
Insights
Adenylyl cyclase VI benefits the heart by activating Akt, which phosphorylates phospholamban. This improves cardiac function independently of beta-adrenergic signaling, offering potential for treating heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Increased adenylyl cyclase VI expression benefits the heart.
- Elevating cAMP in cardiac cells is often detrimental.
- Adenylyl cyclase VI's beneficial effects may be independent of beta-adrenergic signaling.
Purpose of the Study:
- Investigate adenylyl cyclase VI's influence on phospholamban phosphorylation.
- Determine if adenylyl cyclase VI activates Akt signaling.
- Explore mechanisms of adenylyl cyclase VI's beneficial cardiac effects.
Main Methods:
- Utilized cultured cardiac myocytes.
- Measured Akt activation via phosphorylation at Ser473 and Thr308.
- Assessed nuclear phospho-Akt levels.
Main Results:
- Increased adenylyl cyclase VI expression activated Akt.
- Activated Akt phosphorylated phospholamban.
- This process occurred independently of beta-adrenergic receptor stimulation and protein kinase A.
Conclusions:
- Adenylyl cyclase VI activates Akt, leading to phospholamban phosphorylation.
- These signaling events enhance cardiac calcium handling and function.
- This pathway may improve function in the failing heart, independent of beta-adrenergic pathways.
Related Concept Videos
Intracellular Signaling Cascades
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

